logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Provider-initiated HIV testing and counselling for TB in low HIV prevalence settings: is it worthwhile? | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Provider-initiated HIV testing and counselling for TB in low HIV prevalence settings: is it worthwhile?

Nagai S, Robinson R, Rahamefy JR, Randriambeloson SJ, Ranaivomanana DA, Razafindranaivo T, Rakotobe L, Ranaivo A, Hinderaker SG, Harries AD, Zachariah R
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
BACKGROUND
We assessed the HIV-positive yield of offering provider-initiated HIV testing and counselling (PITC) for TB and the costs, in Madagascar, which has a low HIV prevalence and a high TB burden.

METHODS
A cross-sectional study of routinely collected records from January 2010 to June 2011.

RESULTS
A total of 37 596 TB patients were registered in 205 TB centres. HIV testing was available in 95 (46%) of centres where 7524 (40%) of those offered testing accepted it. Only 35 (0.5%) individuals were found HIV positive. Initial costs were about US$1.4 million and annual recurrent costs about US$0.1 million.

CONCLUSION
There are concerns of cost investment for countrywide introduction of PITC in a low HIV prevalence setting.

Countries

Madagascar

Subject Area

tuberculosisSORT-ITHIV/AIDS

Languages

English
DOI
10.1093/trstmh/trt116
Published Date
23 Jan 2014
PubMed ID
24463718
Journal
Transactions of the Royal Society of Tropical Medicine and Hygiene
Volume | Issue | Pages
Volume 108, Issue 3, Pages 173-175
Issue Date
2014-01-23
Dimensions Badge